Stromal	B:C1336512
alterations	I:C1336512
in	O
ovarian	O
cancers	I:C0029925
via	O
wavelength	O
dependent	O
Second	O
Harmonic	I:C0026018
Generation	I:C0026018
microscopy	I:C0026018
and	O
optical	O
scattering	O
.	O

Stromal	O
alterations	I:C1336512
in	O
ovarian	B:C0029925
cancers	I:C0029925
via	O
wavelength	O
dependent	O
Second	O
Harmonic	I:C0026018
Generation	I:C0026018
microscopy	I:C0026018
and	O
optical	O
scattering	O
.	O

Stromal	O
alterations	I:C1336512
in	O
ovarian	O
cancers	I:C0029925
via	O
wavelength	O
dependent	O
Second	B:C0026018
Harmonic	I:C0026018
Generation	I:C0026018
microscopy	I:C0026018
and	O
optical	O
scattering	O
.	O

Ovarian	B:C0029925
cancer	I:C0029925
remains	O
the	O
most	O
deadly	O
gynecological	O
cancer	O
with	O
a	O
poor	O
aggregate	O
survival	O
rate	O
;	O
however	O
,	O
the	O
specific	O
rates	O
are	O
highly	O
dependent	O
on	O
the	O
stage	O
of	O
the	O
disease	O
upon	O
diagnosis	O
.	O

Ovarian	O
cancer	I:C0029925
remains	O
the	O
most	O
deadly	O
gynecological	B:C0018417
cancer	O
with	O
a	O
poor	O
aggregate	O
survival	O
rate	O
;	O
however	O
,	O
the	O
specific	O
rates	O
are	O
highly	O
dependent	O
on	O
the	O
stage	O
of	O
the	O
disease	O
upon	O
diagnosis	O
.	O

Ovarian	O
cancer	I:C0029925
remains	O
the	O
most	O
deadly	O
gynecological	O
cancer	B:C0006826
with	O
a	O
poor	O
aggregate	O
survival	O
rate	O
;	O
however	O
,	O
the	O
specific	O
rates	O
are	O
highly	O
dependent	O
on	O
the	O
stage	O
of	O
the	O
disease	O
upon	O
diagnosis	O
.	O

Ovarian	O
cancer	I:C0029925
remains	O
the	O
most	O
deadly	O
gynecological	O
cancer	O
with	O
a	O
poor	O
aggregate	O
survival	O
rate	O
;	O
however	O
,	O
the	O
specific	O
rates	O
are	O
highly	O
dependent	O
on	O
the	O
stage	O
of	O
the	O
disease	B:C0012634
upon	O
diagnosis	O
.	O

Ovarian	O
cancer	I:C0029925
remains	O
the	O
most	O
deadly	O
gynecological	O
cancer	O
with	O
a	O
poor	O
aggregate	O
survival	O
rate	O
;	O
however	O
,	O
the	O
specific	O
rates	O
are	O
highly	O
dependent	O
on	O
the	O
stage	O
of	O
the	O
disease	O
upon	O
diagnosis	B:C0011900
.	O

Current	O
screening	B:C0220908
and	O
imaging	O
tools	I:C1512629
are	O
insufficient	O
to	O
detect	O
early	O
lesions	I:C0221198
and	O
are	O
not	O
capable	O
of	O
differentiating	O
the	O
subtypes	O
of	O
ovarian	O
cancer	I:C0029925
that	O
may	O
benefit	O
from	O
specific	O
treatments	O
.	O

Current	O
screening	O
and	O
imaging	B:C1512629
tools	I:C1512629
are	O
insufficient	O
to	O
detect	O
early	O
lesions	I:C0221198
and	O
are	O
not	O
capable	O
of	O
differentiating	O
the	O
subtypes	O
of	O
ovarian	O
cancer	I:C0029925
that	O
may	O
benefit	O
from	O
specific	O
treatments	O
.	O

Current	O
screening	O
and	O
imaging	O
tools	I:C1512629
are	O
insufficient	O
to	O
detect	O
early	B:C0221198
lesions	I:C0221198
and	O
are	O
not	O
capable	O
of	O
differentiating	O
the	O
subtypes	O
of	O
ovarian	O
cancer	I:C0029925
that	O
may	O
benefit	O
from	O
specific	O
treatments	O
.	O

Current	O
screening	O
and	O
imaging	O
tools	I:C1512629
are	O
insufficient	O
to	O
detect	O
early	O
lesions	I:C0221198
and	O
are	O
not	O
capable	O
of	O
differentiating	O
the	O
subtypes	O
of	O
ovarian	B:C0029925
cancer	I:C0029925
that	O
may	O
benefit	O
from	O
specific	O
treatments	O
.	O

Current	O
screening	O
and	O
imaging	O
tools	I:C1512629
are	O
insufficient	O
to	O
detect	O
early	O
lesions	I:C0221198
and	O
are	O
not	O
capable	O
of	O
differentiating	O
the	O
subtypes	O
of	O
ovarian	O
cancer	I:C0029925
that	O
may	O
benefit	O
from	O
specific	O
treatments	B:C0087111
.	O

As	O
an	O
alternative	O
to	O
current	O
screening	B:C0220908
and	O
imaging	O
tools	I:C1512629
,	O
we	O
utilized	O
wavelength	O
dependent	O
collagen	O
-	O
specific	O
Second	O
Harmonic	I:C0026018
Generation	I:C0026018
(	I:C0026018
SHG	I:C0026018
)	I:C0026018
imaging	I:C0026018
microscopy	I:C0026018
and	O
optical	O
scattering	I:C0027692
measurements	I:C0027692
to	O
probe	O
the	O
structural	O
differences	O
in	O
the	O
extracellular	O
matrix	I:C0015350
(	O
extracellular	O
matrix	I:C0015350
)	O
of	O
normal	O
stroma	O
,	O
benign	O
tumors	I:C0086692
,	O
endometrioid	O
tumors	I:C0474809
,	O
and	O
low	O
and	O
high	O
-	I:C3839280
grade	I:C3839280
serous	I:C3839280
tumors	I:C3839280
.	O

As	O
an	O
alternative	O
to	O
current	O
screening	O
and	O
imaging	B:C1512629
tools	I:C1512629
,	O
we	O
utilized	O
wavelength	O
dependent	O
collagen	O
-	O
specific	O
Second	O
Harmonic	I:C0026018
Generation	I:C0026018
(	I:C0026018
SHG	I:C0026018
)	I:C0026018
imaging	I:C0026018
microscopy	I:C0026018
and	O
optical	O
scattering	I:C0027692
measurements	I:C0027692
to	O
probe	O
the	O
structural	O
differences	O
in	O
the	O
extracellular	O
matrix	I:C0015350
(	O
extracellular	O
matrix	I:C0015350
)	O
of	O
normal	O
stroma	O
,	O
benign	O
tumors	I:C0086692
,	O
endometrioid	O
tumors	I:C0474809
,	O
and	O
low	O
and	O
high	O
-	I:C3839280
grade	I:C3839280
serous	I:C3839280
tumors	I:C3839280
.	O

As	O
an	O
alternative	O
to	O
current	O
screening	O
and	O
imaging	O
tools	I:C1512629
,	O
we	O
utilized	O
wavelength	O
dependent	O
collagen	B:C0009325
-	O
specific	O
Second	O
Harmonic	I:C0026018
Generation	I:C0026018
(	I:C0026018
SHG	I:C0026018
)	I:C0026018
imaging	I:C0026018
microscopy	I:C0026018
and	O
optical	O
scattering	I:C0027692
measurements	I:C0027692
to	O
probe	O
the	O
structural	O
differences	O
in	O
the	O
extracellular	O
matrix	I:C0015350
(	O
extracellular	O
matrix	I:C0015350
)	O
of	O
normal	O
stroma	O
,	O
benign	O
tumors	I:C0086692
,	O
endometrioid	O
tumors	I:C0474809
,	O
and	O
low	O
and	O
high	O
-	I:C3839280
grade	I:C3839280
serous	I:C3839280
tumors	I:C3839280
.	O

As	O
an	O
alternative	O
to	O
current	O
screening	O
and	O
imaging	O
tools	I:C1512629
,	O
we	O
utilized	O
wavelength	O
dependent	O
collagen	O
-	O
specific	O
Second	B:C0026018
Harmonic	I:C0026018
Generation	I:C0026018
(	I:C0026018
SHG	I:C0026018
)	I:C0026018
imaging	I:C0026018
microscopy	I:C0026018
and	O
optical	O
scattering	I:C0027692
measurements	I:C0027692
to	O
probe	O
the	O
structural	O
differences	O
in	O
the	O
extracellular	O
matrix	I:C0015350
(	O
extracellular	O
matrix	I:C0015350
)	O
of	O
normal	O
stroma	O
,	O
benign	O
tumors	I:C0086692
,	O
endometrioid	O
tumors	I:C0474809
,	O
and	O
low	O
and	O
high	O
-	I:C3839280
grade	I:C3839280
serous	I:C3839280
tumors	I:C3839280
.	O

As	O
an	O
alternative	O
to	O
current	O
screening	O
and	O
imaging	O
tools	I:C1512629
,	O
we	O
utilized	O
wavelength	O
dependent	O
collagen	O
-	O
specific	O
Second	O
Harmonic	I:C0026018
Generation	I:C0026018
(	I:C0026018
SHG	I:C0026018
)	I:C0026018
imaging	I:C0026018
microscopy	I:C0026018
and	O
optical	B:C0027692
scattering	I:C0027692
measurements	I:C0027692
to	O
probe	O
the	O
structural	O
differences	O
in	O
the	O
extracellular	O
matrix	I:C0015350
(	O
extracellular	O
matrix	I:C0015350
)	O
of	O
normal	O
stroma	O
,	O
benign	O
tumors	I:C0086692
,	O
endometrioid	O
tumors	I:C0474809
,	O
and	O
low	O
and	O
high	O
-	I:C3839280
grade	I:C3839280
serous	I:C3839280
tumors	I:C3839280
.	O

As	O
an	O
alternative	O
to	O
current	O
screening	O
and	O
imaging	O
tools	I:C1512629
,	O
we	O
utilized	O
wavelength	O
dependent	O
collagen	O
-	O
specific	O
Second	O
Harmonic	I:C0026018
Generation	I:C0026018
(	I:C0026018
SHG	I:C0026018
)	I:C0026018
imaging	I:C0026018
microscopy	I:C0026018
and	O
optical	O
scattering	I:C0027692
measurements	I:C0027692
to	O
probe	O
the	O
structural	B:C1510464
differences	O
in	O
the	O
extracellular	O
matrix	I:C0015350
(	O
extracellular	O
matrix	I:C0015350
)	O
of	O
normal	O
stroma	O
,	O
benign	O
tumors	I:C0086692
,	O
endometrioid	O
tumors	I:C0474809
,	O
and	O
low	O
and	O
high	O
-	I:C3839280
grade	I:C3839280
serous	I:C3839280
tumors	I:C3839280
.	O

As	O
an	O
alternative	O
to	O
current	O
screening	O
and	O
imaging	O
tools	I:C1512629
,	O
we	O
utilized	O
wavelength	O
dependent	O
collagen	O
-	O
specific	O
Second	O
Harmonic	I:C0026018
Generation	I:C0026018
(	I:C0026018
SHG	I:C0026018
)	I:C0026018
imaging	I:C0026018
microscopy	I:C0026018
and	O
optical	O
scattering	I:C0027692
measurements	I:C0027692
to	O
probe	O
the	O
structural	O
differences	O
in	O
the	O
extracellular	B:C0015350
matrix	I:C0015350
(	O
extracellular	O
matrix	I:C0015350
)	O
of	O
normal	O
stroma	O
,	O
benign	O
tumors	I:C0086692
,	O
endometrioid	O
tumors	I:C0474809
,	O
and	O
low	O
and	O
high	O
-	I:C3839280
grade	I:C3839280
serous	I:C3839280
tumors	I:C3839280
.	O

As	O
an	O
alternative	O
to	O
current	O
screening	O
and	O
imaging	O
tools	I:C1512629
,	O
we	O
utilized	O
wavelength	O
dependent	O
collagen	O
-	O
specific	O
Second	O
Harmonic	I:C0026018
Generation	I:C0026018
(	I:C0026018
SHG	I:C0026018
)	I:C0026018
imaging	I:C0026018
microscopy	I:C0026018
and	O
optical	O
scattering	I:C0027692
measurements	I:C0027692
to	O
probe	O
the	O
structural	O
differences	O
in	O
the	O
extracellular	O
matrix	I:C0015350
(	O
extracellular	B:C0015350
matrix	I:C0015350
)	O
of	O
normal	O
stroma	O
,	O
benign	O
tumors	I:C0086692
,	O
endometrioid	O
tumors	I:C0474809
,	O
and	O
low	O
and	O
high	O
-	I:C3839280
grade	I:C3839280
serous	I:C3839280
tumors	I:C3839280
.	O

As	O
an	O
alternative	O
to	O
current	O
screening	O
and	O
imaging	O
tools	I:C1512629
,	O
we	O
utilized	O
wavelength	O
dependent	O
collagen	O
-	O
specific	O
Second	O
Harmonic	I:C0026018
Generation	I:C0026018
(	I:C0026018
SHG	I:C0026018
)	I:C0026018
imaging	I:C0026018
microscopy	I:C0026018
and	O
optical	O
scattering	I:C0027692
measurements	I:C0027692
to	O
probe	O
the	O
structural	O
differences	O
in	O
the	O
extracellular	O
matrix	I:C0015350
(	O
extracellular	O
matrix	I:C0015350
)	O
of	O
normal	O
stroma	B:C0927195
,	O
benign	O
tumors	I:C0086692
,	O
endometrioid	O
tumors	I:C0474809
,	O
and	O
low	O
and	O
high	O
-	I:C3839280
grade	I:C3839280
serous	I:C3839280
tumors	I:C3839280
.	O

As	O
an	O
alternative	O
to	O
current	O
screening	O
and	O
imaging	O
tools	I:C1512629
,	O
we	O
utilized	O
wavelength	O
dependent	O
collagen	O
-	O
specific	O
Second	O
Harmonic	I:C0026018
Generation	I:C0026018
(	I:C0026018
SHG	I:C0026018
)	I:C0026018
imaging	I:C0026018
microscopy	I:C0026018
and	O
optical	O
scattering	I:C0027692
measurements	I:C0027692
to	O
probe	O
the	O
structural	O
differences	O
in	O
the	O
extracellular	O
matrix	I:C0015350
(	O
extracellular	O
matrix	I:C0015350
)	O
of	O
normal	O
stroma	O
,	O
benign	B:C0086692
tumors	I:C0086692
,	O
endometrioid	O
tumors	I:C0474809
,	O
and	O
low	O
and	O
high	O
-	I:C3839280
grade	I:C3839280
serous	I:C3839280
tumors	I:C3839280
.	O

As	O
an	O
alternative	O
to	O
current	O
screening	O
and	O
imaging	O
tools	I:C1512629
,	O
we	O
utilized	O
wavelength	O
dependent	O
collagen	O
-	O
specific	O
Second	O
Harmonic	I:C0026018
Generation	I:C0026018
(	I:C0026018
SHG	I:C0026018
)	I:C0026018
imaging	I:C0026018
microscopy	I:C0026018
and	O
optical	O
scattering	I:C0027692
measurements	I:C0027692
to	O
probe	O
the	O
structural	O
differences	O
in	O
the	O
extracellular	O
matrix	I:C0015350
(	O
extracellular	O
matrix	I:C0015350
)	O
of	O
normal	O
stroma	O
,	O
benign	O
tumors	I:C0086692
,	O
endometrioid	B:C0474809
tumors	I:C0474809
,	O
and	O
low	O
and	O
high	O
-	I:C3839280
grade	I:C3839280
serous	I:C3839280
tumors	I:C3839280
.	O

As	O
an	O
alternative	O
to	O
current	O
screening	O
and	O
imaging	O
tools	I:C1512629
,	O
we	O
utilized	O
wavelength	O
dependent	O
collagen	O
-	O
specific	O
Second	O
Harmonic	I:C0026018
Generation	I:C0026018
(	I:C0026018
SHG	I:C0026018
)	I:C0026018
imaging	I:C0026018
microscopy	I:C0026018
and	O
optical	O
scattering	I:C0027692
measurements	I:C0027692
to	O
probe	O
the	O
structural	O
differences	O
in	O
the	O
extracellular	O
matrix	I:C0015350
(	O
extracellular	O
matrix	I:C0015350
)	O
of	O
normal	O
stroma	O
,	O
benign	O
tumors	I:C0086692
,	O
endometrioid	O
tumors	I:C0474809
,	O
and	O
low	B:C3839184
and	O
high	O
-	I:C3839280
grade	I:C3839280
serous	I:C3839280
tumors	I:C3839280
.	O

As	O
an	O
alternative	O
to	O
current	O
screening	O
and	O
imaging	O
tools	I:C1512629
,	O
we	O
utilized	O
wavelength	O
dependent	O
collagen	O
-	O
specific	O
Second	O
Harmonic	I:C0026018
Generation	I:C0026018
(	I:C0026018
SHG	I:C0026018
)	I:C0026018
imaging	I:C0026018
microscopy	I:C0026018
and	O
optical	O
scattering	I:C0027692
measurements	I:C0027692
to	O
probe	O
the	O
structural	O
differences	O
in	O
the	O
extracellular	O
matrix	I:C0015350
(	O
extracellular	O
matrix	I:C0015350
)	O
of	O
normal	O
stroma	O
,	O
benign	O
tumors	I:C0086692
,	O
endometrioid	O
tumors	I:C0474809
,	O
and	O
low	O
and	O
high	B:C3839280
-	I:C3839280
grade	I:C3839280
serous	I:C3839280
tumors	I:C3839280
.	O

The	O
Second	B:C0026018
Harmonic	I:C0026018
Generation	I:C0026018
signatures	O
of	O
the	O
emission	O
directionality	O
and	O
conversion	O
efficiency	O
as	O
well	O
as	O
the	O
optical	O
scattering	O
are	O
related	O
to	O
the	O
organization	O
of	O
collagen	O
on	O
the	O
sub-micron	O
size	O
scale	I:C0282574
and	O
encode	O
structural	O
information	O
.	O

The	O
Second	O
Harmonic	I:C0026018
Generation	I:C0026018
signatures	O
of	O
the	O
emission	O
directionality	O
and	O
conversion	O
efficiency	O
as	O
well	O
as	O
the	O
optical	O
scattering	O
are	O
related	O
to	O
the	O
organization	O
of	O
collagen	B:C0009325
on	O
the	O
sub-micron	O
size	O
scale	I:C0282574
and	O
encode	O
structural	O
information	O
.	O

The	O
Second	O
Harmonic	I:C0026018
Generation	I:C0026018
signatures	O
of	O
the	O
emission	O
directionality	O
and	O
conversion	O
efficiency	O
as	O
well	O
as	O
the	O
optical	O
scattering	O
are	O
related	O
to	O
the	O
organization	O
of	O
collagen	O
on	O
the	O
sub-micron	O
size	B:C0282574
scale	I:C0282574
and	O
encode	O
structural	O
information	O
.	O

The	O
Second	O
Harmonic	I:C0026018
Generation	I:C0026018
signatures	O
of	O
the	O
emission	O
directionality	O
and	O
conversion	O
efficiency	O
as	O
well	O
as	O
the	O
optical	O
scattering	O
are	O
related	O
to	O
the	O
organization	O
of	O
collagen	O
on	O
the	O
sub-micron	O
size	O
scale	I:C0282574
and	O
encode	O
structural	B:C1510464
information	O
.	O

The	O
wavelength	O
dependence	O
of	O
these	O
readouts	O
adds	O
additional	O
characterization	O
of	O
the	O
size	B:C0456389
and	O
distribution	O
of	O
collagen	O
fibrils	I:C1179626
/	O
fibers	O
relative	O
to	O
the	O
interrogating	O
wavelengths	O
.	O

The	O
wavelength	O
dependence	O
of	O
these	O
readouts	O
adds	O
additional	O
characterization	O
of	O
the	O
size	O
and	O
distribution	O
of	O
collagen	B:C1179626
fibrils	I:C1179626
/	O
fibers	O
relative	O
to	O
the	O
interrogating	O
wavelengths	O
.	O

The	O
wavelength	O
dependence	O
of	O
these	O
readouts	O
adds	O
additional	O
characterization	O
of	O
the	O
size	O
and	O
distribution	O
of	O
collagen	O
fibrils	I:C1179626
/	O
fibers	B:C0225325
relative	O
to	O
the	O
interrogating	O
wavelengths	O
.	O

We	O
found	O
a	O
strong	O
wavelength	O
dependence	O
of	O
these	O
metrics	B:C0015350
that	O
are	O
related	O
to	O
significant	O
structural	O
differences	O
in	O
the	O
collagen	O
organization	O
and	O
are	O
consistent	O
with	O
the	O
dualistic	O
classification	O
of	O
type	O
I	I:C0476122
and	I:C0476122
II	I:C0476122
serous	I:C0476122
tumors	I:C0476122
.	O

We	O
found	O
a	O
strong	O
wavelength	O
dependence	O
of	O
these	O
metrics	O
that	O
are	O
related	O
to	O
significant	O
structural	B:C1510464
differences	O
in	O
the	O
collagen	O
organization	O
and	O
are	O
consistent	O
with	O
the	O
dualistic	O
classification	O
of	O
type	O
I	I:C0476122
and	I:C0476122
II	I:C0476122
serous	I:C0476122
tumors	I:C0476122
.	O

We	O
found	O
a	O
strong	O
wavelength	O
dependence	O
of	O
these	O
metrics	O
that	O
are	O
related	O
to	O
significant	O
structural	O
differences	O
in	O
the	O
collagen	B:C0009325
organization	O
and	O
are	O
consistent	O
with	O
the	O
dualistic	O
classification	O
of	O
type	O
I	I:C0476122
and	I:C0476122
II	I:C0476122
serous	I:C0476122
tumors	I:C0476122
.	O

We	O
found	O
a	O
strong	O
wavelength	O
dependence	O
of	O
these	O
metrics	O
that	O
are	O
related	O
to	O
significant	O
structural	O
differences	O
in	O
the	O
collagen	O
organization	O
and	O
are	O
consistent	O
with	O
the	O
dualistic	O
classification	B:C0008902
of	O
type	O
I	I:C0476122
and	I:C0476122
II	I:C0476122
serous	I:C0476122
tumors	I:C0476122
.	O

We	O
found	O
a	O
strong	O
wavelength	O
dependence	O
of	O
these	O
metrics	O
that	O
are	O
related	O
to	O
significant	O
structural	O
differences	O
in	O
the	O
collagen	O
organization	O
and	O
are	O
consistent	O
with	O
the	O
dualistic	O
classification	O
of	O
type	B:C0476122
I	I:C0476122
and	I:C0476122
II	I:C0476122
serous	I:C0476122
tumors	I:C0476122
.	O

Moreover	O
,	O
type	B:C0474809
I	I:C0474809
endometrioid	I:C0474809
tumors	I:C0474809
have	O
strongly	O
differing	O
extracellular	O
matrix	I:C0015350
architecture	O
than	O
the	O
serous	O
malignancies	I:C0476122
.	O

Moreover	O
,	O
type	O
I	I:C0474809
endometrioid	I:C0474809
tumors	I:C0474809
have	O
strongly	O
differing	O
extracellular	B:C0015350
matrix	I:C0015350
architecture	O
than	O
the	O
serous	O
malignancies	I:C0476122
.	O

Moreover	O
,	O
type	O
I	I:C0474809
endometrioid	I:C0474809
tumors	I:C0474809
have	O
strongly	O
differing	O
extracellular	O
matrix	I:C0015350
architecture	O
than	O
the	O
serous	B:C0476122
malignancies	I:C0476122
.	O

The	O
Second	B:C0026018
Harmonic	I:C0026018
Generation	I:C0026018
metrics	O
and	O
optical	O
scattering	I:C0027692
measurements	I:C0027692
were	O
used	O
to	O
form	O
a	O
linear	O
discriminant	I:C3161035
model	I:C3161035
to	O
classify	O
the	O
tissues	O
,	O
and	O
we	O
obtained	O
high	O
accuracy	O
(	O
>90	O
%	O
)	O
between	O
high	O
-	I:C3839280
grade	I:C3839280
serous	I:C3839280
tumors	I:C3839280
from	O
the	O
other	O
tissue	O
types	I:C2713035
.	O

The	O
Second	O
Harmonic	I:C0026018
Generation	I:C0026018
metrics	B:C0015350
and	O
optical	O
scattering	I:C0027692
measurements	I:C0027692
were	O
used	O
to	O
form	O
a	O
linear	O
discriminant	I:C3161035
model	I:C3161035
to	O
classify	O
the	O
tissues	O
,	O
and	O
we	O
obtained	O
high	O
accuracy	O
(	O
>90	O
%	O
)	O
between	O
high	O
-	I:C3839280
grade	I:C3839280
serous	I:C3839280
tumors	I:C3839280
from	O
the	O
other	O
tissue	O
types	I:C2713035
.	O

The	O
Second	O
Harmonic	I:C0026018
Generation	I:C0026018
metrics	O
and	O
optical	B:C0027692
scattering	I:C0027692
measurements	I:C0027692
were	O
used	O
to	O
form	O
a	O
linear	O
discriminant	I:C3161035
model	I:C3161035
to	O
classify	O
the	O
tissues	O
,	O
and	O
we	O
obtained	O
high	O
accuracy	O
(	O
>90	O
%	O
)	O
between	O
high	O
-	I:C3839280
grade	I:C3839280
serous	I:C3839280
tumors	I:C3839280
from	O
the	O
other	O
tissue	O
types	I:C2713035
.	O

The	O
Second	O
Harmonic	I:C0026018
Generation	I:C0026018
metrics	O
and	O
optical	O
scattering	I:C0027692
measurements	I:C0027692
were	O
used	O
to	O
form	O
a	O
linear	B:C3161035
discriminant	I:C3161035
model	I:C3161035
to	O
classify	O
the	O
tissues	O
,	O
and	O
we	O
obtained	O
high	O
accuracy	O
(	O
>90	O
%	O
)	O
between	O
high	O
-	I:C3839280
grade	I:C3839280
serous	I:C3839280
tumors	I:C3839280
from	O
the	O
other	O
tissue	O
types	I:C2713035
.	O

The	O
Second	O
Harmonic	I:C0026018
Generation	I:C0026018
metrics	O
and	O
optical	O
scattering	I:C0027692
measurements	I:C0027692
were	O
used	O
to	O
form	O
a	O
linear	O
discriminant	I:C3161035
model	I:C3161035
to	O
classify	O
the	O
tissues	B:C0040300
,	O
and	O
we	O
obtained	O
high	O
accuracy	O
(	O
>90	O
%	O
)	O
between	O
high	O
-	I:C3839280
grade	I:C3839280
serous	I:C3839280
tumors	I:C3839280
from	O
the	O
other	O
tissue	O
types	I:C2713035
.	O

The	O
Second	O
Harmonic	I:C0026018
Generation	I:C0026018
metrics	O
and	O
optical	O
scattering	I:C0027692
measurements	I:C0027692
were	O
used	O
to	O
form	O
a	O
linear	O
discriminant	I:C3161035
model	I:C3161035
to	O
classify	O
the	O
tissues	O
,	O
and	O
we	O
obtained	O
high	O
accuracy	O
(	O
>90	O
%	O
)	O
between	O
high	B:C3839280
-	I:C3839280
grade	I:C3839280
serous	I:C3839280
tumors	I:C3839280
from	O
the	O
other	O
tissue	O
types	I:C2713035
.	O

The	O
Second	O
Harmonic	I:C0026018
Generation	I:C0026018
metrics	O
and	O
optical	O
scattering	I:C0027692
measurements	I:C0027692
were	O
used	O
to	O
form	O
a	O
linear	O
discriminant	I:C3161035
model	I:C3161035
to	O
classify	O
the	O
tissues	O
,	O
and	O
we	O
obtained	O
high	O
accuracy	O
(	O
>90	O
%	O
)	O
between	O
high	O
-	I:C3839280
grade	I:C3839280
serous	I:C3839280
tumors	I:C3839280
from	O
the	O
other	O
tissue	B:C2713035
types	I:C2713035
.	O

High	B:C3839280
-	I:C3839280
grade	I:C3839280
serous	I:C3839280
tumors	I:C3839280
account	O
for	O
~	O
70	O
%	O
of	O
ovarian	O
cancers	I:C0029925
,	O
and	O
this	O
delineation	O
has	O
potential	O
clinical	O
applications	O
in	O
terms	O
of	O
supplementing	O
histological	O
analysis	O
,	O
understanding	O
the	O
etiology	O
,	O
as	O
well	O
as	O
development	O
of	O
an	O
in	O
vivo	O
screening	O
tool	I:C0220908
.	O

High	O
-	I:C3839280
grade	I:C3839280
serous	I:C3839280
tumors	I:C3839280
account	O
for	O
~	O
70	O
%	O
of	O
ovarian	B:C0029925
cancers	I:C0029925
,	O
and	O
this	O
delineation	O
has	O
potential	O
clinical	O
applications	O
in	O
terms	O
of	O
supplementing	O
histological	O
analysis	O
,	O
understanding	O
the	O
etiology	O
,	O
as	O
well	O
as	O
development	O
of	O
an	O
in	O
vivo	O
screening	O
tool	I:C0220908
.	O

High	O
-	I:C3839280
grade	I:C3839280
serous	I:C3839280
tumors	I:C3839280
account	O
for	O
~	O
70	O
%	O
of	O
ovarian	O
cancers	I:C0029925
,	O
and	O
this	O
delineation	O
has	O
potential	O
clinical	O
applications	O
in	O
terms	O
of	O
supplementing	O
histological	O
analysis	O
,	O
understanding	O
the	O
etiology	O
,	O
as	O
well	O
as	O
development	O
of	O
an	O
in	O
vivo	O
screening	B:C0220908
tool	I:C0220908
.	O

Second	B:C0026018
Harmonic	I:C0026018
Generation	I:C0026018
and	O
optical	O
scattering	I:C0027692
measurements	I:C0027692
provide	O
sub-resolution	O
information	O
and	O
when	O
combined	O
provide	O
superior	O
diagnostic	I:C0430022
power	I:C0430022
over	O
clinical	O
imaging	I:C0011923
modalities	O
.	O

Second	O
Harmonic	I:C0026018
Generation	I:C0026018
and	O
optical	B:C0027692
scattering	I:C0027692
measurements	I:C0027692
provide	O
sub-resolution	O
information	O
and	O
when	O
combined	O
provide	O
superior	O
diagnostic	I:C0430022
power	I:C0430022
over	O
clinical	O
imaging	I:C0011923
modalities	O
.	O

Second	O
Harmonic	I:C0026018
Generation	I:C0026018
and	O
optical	O
scattering	I:C0027692
measurements	I:C0027692
provide	O
sub-resolution	O
information	O
and	O
when	O
combined	O
provide	O
superior	B:C0430022
diagnostic	I:C0430022
power	I:C0430022
over	O
clinical	O
imaging	I:C0011923
modalities	O
.	O

Second	O
Harmonic	I:C0026018
Generation	I:C0026018
and	O
optical	O
scattering	I:C0027692
measurements	I:C0027692
provide	O
sub-resolution	O
information	O
and	O
when	O
combined	O
provide	O
superior	O
diagnostic	I:C0430022
power	I:C0430022
over	O
clinical	B:C0011923
imaging	I:C0011923
modalities	O
.	O

Additionally	O
the	O
measurements	O
are	O
able	O
to	O
delineate	O
the	O
different	O
subtypes	O
of	O
ovarian	B:C0029925
cancer	I:C0029925
and	O
may	O
potentially	O
assist	O
in	O
treatment	O
protocols	I:C0040808
.	O

Additionally	O
the	O
measurements	O
are	O
able	O
to	O
delineate	O
the	O
different	O
subtypes	O
of	O
ovarian	O
cancer	I:C0029925
and	O
may	O
potentially	O
assist	O
in	O
treatment	B:C0040808
protocols	I:C0040808
.	O

Understanding	O
the	O
altered	O
collagen	B:C0009325
assembly	O
can	O
supplement	O
histological	O
analysis	O
and	O
provide	O
new	O
insight	O
into	O
the	O
etiology	O
.	O

These	O
methods	O
could	O
become	O
an	O
in	O
vivo	O
screening	B:C0220908
tool	I:C0220908
for	O
earlier	O
detection	O
which	O
is	O
important	O
since	O
ovarian	O
malignancies	I:C1140680
can	O
metastasize	O
while	O
undetectable	O
by	O
current	O
clinical	O
imaging	I:C0011923
resolution	O
.	O

These	O
methods	O
could	O
become	O
an	O
in	O
vivo	O
screening	O
tool	I:C0220908
for	O
earlier	O
detection	O
which	O
is	O
important	O
since	O
ovarian	B:C1140680
malignancies	I:C1140680
can	O
metastasize	O
while	O
undetectable	O
by	O
current	O
clinical	O
imaging	I:C0011923
resolution	O
.	O

These	O
methods	O
could	O
become	O
an	O
in	O
vivo	O
screening	O
tool	I:C0220908
for	O
earlier	O
detection	O
which	O
is	O
important	O
since	O
ovarian	O
malignancies	I:C1140680
can	O
metastasize	B:C0027627
while	O
undetectable	O
by	O
current	O
clinical	O
imaging	I:C0011923
resolution	O
.	O

These	O
methods	O
could	O
become	O
an	O
in	O
vivo	O
screening	O
tool	I:C0220908
for	O
earlier	O
detection	O
which	O
is	O
important	O
since	O
ovarian	O
malignancies	I:C1140680
can	O
metastasize	O
while	O
undetectable	O
by	O
current	O
clinical	B:C0011923
imaging	I:C0011923
resolution	O
.	O

